On a recent episode of the America’s Nest Egg podcast, host and Ancera CEO Arjun Ganesan spoke with Aaron Schacht, CEO of BiomEdit. With over 30 years of experience, Schacht has served as executive vice president at Elanco Animal Health, and in various research and development positions at Eli Lilly and Company.
Throughout the conversation, Schacht highlighted the progress made in human health due to significant investments and risk-taking ecosystems, and how this progress shows the potential for similar advancements in animal health. Schacht is a scientist by training, starting his career in 1990 as a research chemist at Eli Lilly and Company.
“We’re entering a new era in animal health where all of the findings and learnings and all the tools that have been developed on the human health side can be applied in animal health, but we’re not waiting for them to develop over time. They’re all there now,” Schacht said.
Schacht described synthetic biology as “a collective term for anything you would do to engineer a cell,” and discussed how BiomEdit is applying it to change and raise the expectations of livestock producers, veterinarians, and pet owners.
